Hovid Bhd (“Hovid”) wishes to announce that Hovid has just received the manufacturing licence for our Chemor Plant at Lot 56442, 7 ½ Miles, Jalan Ipoh/Chemor, 31200 Chemor, Perak, today, from the National Pharmaceutical Control Bureau under the Ministry of Health Malaysia. The licence is valid from 6 March 2017, to be renewed three months prior to the expiry date on 31 December 2017.
However, the manufacturing licence for Ipoh Plant at 121, Jalan Tunku Abdul Rahman (formerly Jalan Kuala Kangsar), 30010 Ipoh, Perak, is pending the completion of corrective actions which are currently in progress. Hovid targets to complete the necessary corrective actions at Ipoh Plant to comply with the Current Good Manufacturing Practice (“cGMP”) required by the National Pharmaceutical Regulatory Department (“NPRA”) by end of March 2017, and submit the necessary reports to NPRA immediately thereafter. The re-issuance of the licence will be subject to NPRA being satisfied with our corrective actions taken. We estimate to receive the decision from NPRA for our Ipoh Plant by end of May 2017.
hovid share price was stagnant all the time. it might bcoz of someone had knew the wrong packaging incident. with the license recovered, it's now no barrier to hold the price movement.
if u r banging it big time.. check out tocovid studies... if that study is approved... u r sitting on a gold mine now at phase 2.. wait and see the trials results
3 days dogi showing indecision n trend changes, followed by small body harami which gives a positive indication but needs conformation. If the price strengthen , then we may see a break out soon!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
lowbuyhighsell
235 posts
Posted by lowbuyhighsell > 2017-03-06 21:05 | Report Abuse
Hovid Bhd (“Hovid”) wishes to announce that Hovid has just received the manufacturing licence for our Chemor Plant at Lot 56442, 7 ½ Miles, Jalan Ipoh/Chemor, 31200 Chemor, Perak, today, from the National Pharmaceutical Control Bureau under the Ministry of Health Malaysia. The licence is valid from 6 March 2017, to be renewed three months prior to the expiry date on 31 December 2017.
However, the manufacturing licence for Ipoh Plant at 121, Jalan Tunku Abdul Rahman (formerly Jalan Kuala Kangsar), 30010 Ipoh, Perak, is pending the completion of corrective actions which are currently in progress. Hovid targets to complete the necessary corrective actions at Ipoh Plant to comply with the Current Good Manufacturing Practice (“cGMP”) required by the National Pharmaceutical Regulatory Department (“NPRA”) by end of March 2017, and submit the necessary reports to NPRA immediately thereafter. The re-issuance of the licence will be subject to NPRA being satisfied with our corrective actions taken. We estimate to receive the decision from NPRA for our Ipoh Plant by end of May 2017.
This announcement is dated 6 March 2017.